ROAM OA: Functional and Patient Reported Outcomes Wearing a Knee Brace for Unicompartmental OA
1 other identifier
interventional
30
1 country
1
Brief Summary
The aim of this study is to conduct a comparative evaluation of the ROAM OA Single Upright Brace and the Ossur Unloader One Knee Brace in subjects with medial compartment osteoarthritis. The focus is on comparing the immediate and short-term biomechanical effects of these braces on knee adduction moments and spatiotemporal gait parameters, as well as assessing the long-term efficacy of the ROAM OA brace in improving pain and functional outcomes for individuals with osteoarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable knee-osteoarthritis
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2025
CompletedFirst Posted
Study publicly available on registry
November 5, 2025
CompletedStudy Start
First participant enrolled
April 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
May 12, 2026
April 1, 2026
11 months
October 28, 2025
May 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in knee adduction moment during gait
Change in peak knee adduction moment measured during gait analysis using instrumented motion capture and force platforms. Comparisons are made between baseline, 4 weeks, and 8 weeks.
Baseline, 4 weeks, and 8 weeks
Change in Visual Analog Scale (VAS) walking pain
Change in walking pain measured by the Visual Analog Scale (VAS), in which participants rate their pain during walking along a 10-centimeter line ranging from 0 = no pain to 10 = worst imaginable pain. Lower scores indicate less pain and therefore a better outcome. Comparisons will be made between baseline, 4 weeks, and 8 weeks.
Baseline, 4 weeks, and 8 weeks
Secondary Outcomes (2)
Change in KOOS (Knee injury and Osteoarthritis Outcome Score) subscale scores
Baseline, 4 weeks, and 8 weeks
Change in knee range of motion (ROM)
Baseline, 4 weeks, and 8 weeks
Study Arms (2)
ROAM OA brace
EXPERIMENTALParticipants receive the ROAM OA Single Upright Knee Brace (Enovis) to wear daily for the study duration. The brace is designed to offload the medial compartment of the knee and improve pain and function.
Active Comparator: Unloader brace or standard of care
ACTIVE COMPARATORParticipants receive the Ossur Unloader One knee brace or no brace (standard of care) and will follow standard pain management and physical therapy guidelines. This group serves as an active comparator to the ROAM OA brace.
Interventions
A commercially available single-upright knee brace designed to offload the medial compartment of the knee in patients with unicompartmental osteoarthritis; manufactured by Enovis. Participants will wear the brace daily for the duration of the study.
Participants will receive the Ossur Unloader One knee brace or no brace (standard of care) and will follow standard management and physical therapy guidelines. This group serves as the active comparator to the ROAM OA brace.
Eligibility Criteria
You may qualify if:
- Age 40-85 years.
- BMI ≤ 35.
- Physician-diagnosed medial compartment knee osteoarthritis.
- Visual Analog Scale (VAS) walking pain ≥ 4.
- Willing to wear assigned brace ≥ 4 hours/day.
- Able to walk independently for 20 minutes unaided.
- Stable pain medication regimen ≥ 4 weeks.
- ≥3 months since last hyaluronic acid (HA), platelet-rich plasma (PRP), or steroid injection.
You may not qualify if:
- Lateral or patellofemoral osteoarthritis.
- Prior knee replacement.
- Significant ligament injury or acute lower limb injury.
- Neurological condition affecting gait.
- Severe psychiatric or neurological disorder affecting pain perception.
- Skin condition or allergy preventing brace use.
- Current use of another brace or assistive device.
- Recent opioid or corticosteroid use (\<4 weeks).
- Pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rush University Medical Centerlead
- Enoviscollaborator
Study Sites (1)
Rush University Medical Center
Chicago, Illinois, 60612, United States
Related Publications (2)
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74. doi: 10.1002/acr.21596.
PMID: 22563589BACKGROUNDChang J, Yuan Y, Fu M, Wang D. Health-related quality of life among patients with knee osteoarthritis in Guangzhou, China: a multicenter cross-sectional study. Health Qual Life Outcomes. 2023 May 27;21(1):50. doi: 10.1186/s12955-023-02133-x.
PMID: 37244981BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No blinding; all participants and study team are aware of the assigned brace.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Grainger Director of the RUSH Arthritis and Orthopedics Institute
Study Record Dates
First Submitted
October 28, 2025
First Posted
November 5, 2025
Study Start
April 27, 2026
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
May 12, 2026
Record last verified: 2026-04